Physician Awareness of FDA’s Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 Pandemic | Synapse
March 3, 2026
Physician Awareness of FDA’s Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 Pandemic
Key Points
Increased physician awareness of FDA changes likely influenced prescribing behaviors during COVID-19.
Among the providers surveyed, over 70% noted shifts in laboratory testing requirements for prescriptions.
Assessment of prescribing practices amidst the COVID-19 pandemic revealed significant deviations from prior standards.
Implications of altered REMS regulations highlight the need for continued monitoring of clinical practices.